Glythera makes two senior appointments
April 3, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing burns, evetts, glythera
Newcastle-based biotech firm Glythera has appointed Dr Nigel Burns as non-executive director and Ian Evetts as commercial director. Burns (pictured) …
FDA slams GSK for manufacturing oversights
April 3, 2014Manufacturing and Production FDA, GMP, GSK, Ireland, cork, mage, manufacturing
The FDA has warned GlaxoSmithKline that the US importation of products from the firm’s facility in Cork, Ireland could be …
Steve McCairns joins PCI as UK director
April 3, 2014Manufacturing and Production, Research and Development, Sales and Marketing PCI, mccairns
Packaging firm PCI has welcomed Steve McCairns as its director of operations for its UK business.

 McCairns is a Lean …
EU votes for trial transparency
April 3, 2014Research and Development, Sales and Marketing ABPI, EFPIA, EU, Goldacre, UK, alltrials, transparency, willmott
Europe took a decisive step toward forcing pharma to open up its clinical trial data last night, after the EU …
Lundbeck teams up with Lieber Institute
April 3, 2014Research and Development, Sales and Marketing Astellas, AstraZeneca, Lundbeck, Pfizer, Roche, ability, brain, lieber, lilly
Lundbeck has entered into a new partnership with the Lieber Institute for Brain Development in the hope of discovering new …
Research pact joins Pfizer and Merck Serono with academics
April 3, 2014Research and Development, Sales and Marketing Lupus, Merck Serono, Pfizer, broad institute, emd, kidney
Merck’s US affiliate EMD Serono and Pfizer have entered into a research agreement with the Broad Institute to investigate autoimmune …
Langland appoints director of planning
April 3, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adrian Zambardino, Langland
Creative healthcare ad agency Langland has appointed Adrian Zambardino as its director of planning. Zambardino has more than 25 years …
Inhaled insulin one step closer to approval
April 3, 2014Sales and Marketing Afrezza, FDA, Mannkind, diabetes, type 1, type 2
After a rocky few years MannKind’s inhaled insulin Afrezza finally looks to be on the path to approval in the …
GSK China rep speaks out over ‘bribery culture’
April 2, 2014Medical Communications, Sales and Marketing China, GSK, Shanghai, Witty, bribery, sales
A former sales representative for GlaxoSmithKline has spoken of the firm’s alleged tactics in bribing poorly paid doctors in China …
PAN promotes within its ranks
April 2, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pan, claire hay
Claire Hay has been promoted to associate director at creative comms agency PAN. Hay joined the agency as a senior account …
‘More patients want Votrient’
April 2, 2014Research and Development, Sales and Marketing Cancer, GSK, Pfizer, Sutent, Votrient
GlaxoSmithKline is looking at patient satisfaction as a potential marketing tool for its kidney cancer drug Votrient, setting up a …
Lung cancer vaccine dropped
April 2, 2014Research and Development, Sales and Marketing GSK, MAGE-A3, NSCLC, Vaccine, lung cancer, magrit
GlaxoSmithKline took a hit today after its lung cancer vaccine MAGE-A3 failed to benefit patients. The London-based firm has now …
Sanofi appoints a chief patient officer
April 2, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, anne beal
Sanofi has hired Dr Anne Beal to the newly-created position of chief patient officer. The move to hire such a …
‘Stakes never higher’ for NHS
April 2, 2014Sales and Marketing CCGs, NHS England, Simon Stevens, UK
The new boss of NHS England has warned that he will not be able to fix its problems and said …
The Biogerontology Research Foundation makes board appointment
April 1, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dmitry Kaminskiy, The Biogerontology Research Foundation
UK charity The Biogerontology Research Foundation has appointed Dmitry Kaminskiy to its board of trustees. Kaminskiy is the managing director of …
Votrient’s extended licence application ditched
April 1, 2014Sales and Marketing EMA, Europe, GSK, ovarian, votrient kidney cancer
GlaxoSmithKline admits it is ‘disappointed’ after abandoning its attempt to extend kidney cancer drug Votrient’s licence to take in ovarian …
Polyhedra Group appoints Steve Hobbs
April 1, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing polyhedra group, steve hobbs
Steve Hobbs has been appointed chief business development officer for The Polyhedra Group. Hobbs has over 30 years’ international experience …
UK clinical trials system not working during epidemics
April 1, 2014Research and Development, Sales and Marketing Farrar, clinical trials, epidemics, welcome trust
The new director of medical charity the Wellcome Trust has told a British newspaper that the slow-paced nature of clinical …
Red Door Communications hires Sandie Dinning
April 1, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Red Door Communications, sandy dinning
Sandie Dinning has joined comms agency Red Door Communications and is to launch a new youth and community engagement offering …
GSK invests £130m in Africa
April 1, 2014Manufacturing and Production, Research and Development, Sales and Marketing Africa, GSK, Nigeria, kenya, rwanda, sub-saharan
GlaxoSmithKline is to invest £130 million in sub-Saharan Africa over the next five years – money which the company says …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
